{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:17:26Z","timestamp":1773105446690,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"National Research Development and Innovation Office","doi-asserted-by":"crossref","award":["OTKA 108518"],"award-info":[{"award-number":["OTKA 108518"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Brain Research Program","award":["NAP-KTIA-13-NAP-A-III\/9"],"award-info":[{"award-number":["NAP-KTIA-13-NAP-A-III\/9"]}]},{"name":"Euroheadpain-FP7-Health-2013-Innovation","award":["602633"],"award-info":[{"award-number":["602633"]}]},{"name":"Economic Development and Innovation Operational Programme","award":["GINOP-2.3.2-15-2016-00034"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00034"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jns.2017.02.053","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T07:47:50Z","timestamp":1488268070000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum"],"prefix":"10.1016","volume":"376","author":[{"given":"Reza","family":"Samavati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-0564","authenticated-orcid":false,"given":"Ferenc","family":"Z\u00e1dor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edina","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadett","family":"Tuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di\u00e1na","family":"Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Veres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3bert","family":"G\u00e1sp\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n M.","family":"M\u00e1ndity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Benyhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Borsodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.02.053_bb0005","first-page":"17","article-title":"Biochemistry of opioid (morphine) receptors: binding, structure and molecular modelling","volume":"59","author":"Benyhe","year":"2015","journal-title":"Acta Biol. Szeged."},{"key":"10.1016\/j.jns.2017.02.053_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/bj3480531","article-title":"G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity","volume":"537","author":"Burford","year":"2000","journal-title":"Biochem. J."},{"issue":"Suppl","key":"10.1016\/j.jns.2017.02.053_bb0015","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1038\/sj.bjp.0706435","article-title":"75 years of opioid research: the exciting but vain quest for the Holy Grail","volume":"147","author":"Corbett","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jns.2017.02.053_bb0020","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","article-title":"G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast","volume":"60","author":"Cosi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2017.02.053_bb0025","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s11064-013-1139-4","article-title":"Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia\/reperfusion injury in rats","volume":"38","author":"Fang","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature12944","article-title":"Molecular control of \u03b4-opioid receptor signalling","volume":"506","author":"Fenalti","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jns.2017.02.053_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pbb.2003.10.001","article-title":"Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid","volume":"77","author":"F\u00fcvesi","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jns.2017.02.053_bb0040","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.STR.0000072512.30658.E7","article-title":"Neuroprotective-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats","volume":"34","author":"Goyagi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2017.02.053_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(96)00822-0","article-title":"Ultrastructural immunocytochemical localization of the N-methyl-d-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens","volume":"739","author":"Gracy","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0050","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.17-12-04839.1997","article-title":"Dual ultrastructural localization of \u03bc-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens","volume":"17","author":"Gracy","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.02.053_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/phrs.1998.0362","article-title":"The analgesic effects of tryptophan and its metabolites in the rat","volume":"38","author":"Heyliger","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0306-4522(94)90480-4","article-title":"Immunohistochemical localization of mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein","volume":"62","author":"Hiller","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2017.02.053_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2007.04.017","article-title":"Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level","volume":"1155","author":"Horvath","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u03bc-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jns.2017.02.053_bb0075","doi-asserted-by":"crossref","first-page":"15304","DOI":"10.1523\/JNEUROSCI.4255-10.2010","article-title":"Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits","volume":"30","author":"Kam","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.02.053_bb0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jns.2017.02.053_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(02)01787-9","article-title":"The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats","volume":"445","author":"Kekesi","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jns.2017.02.053_bb0090","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-3565(25)10203-6","article-title":"Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection","volume":"264","author":"Koek","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jns.2017.02.053_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0014-2999(89)90339-7","article-title":"[3H]MK-801 binding sites in post-mortem human frontal cortex","volume":"162","author":"Kornhuber","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jns.2017.02.053_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0091-3057(00)00443-3","article-title":"Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats","volume":"68","author":"Kotli\u0144ska","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jns.2017.02.053_bb0105","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","author":"Lovelace","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2017.02.053_bb0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0165-0173(99)00020-X","article-title":"NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity","volume":"30","author":"Mao","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jns.2017.02.053_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(91)90576-H","article-title":"Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat","volume":"547","author":"Marek","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0120","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.17-01-00011.1997","article-title":"\u03bc-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons","volume":"17","author":"Martin","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.02.053_bb0125","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1213\/ane.0b013e3181b21c5e","article-title":"The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model","volume":"109","author":"Mecs","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jns.2017.02.053_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2009.07.100","article-title":"Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat","volume":"1295","author":"Morgan","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2017.02.053_bb0135","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1016\/j.bmc.2011.10.029","article-title":"Synthesis and biological effects of some kynurenic acid analogs","volume":"19","author":"Nagy","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jns.2017.02.053_bb0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00702-011-0665-y","article-title":"Kynurenines and headache","volume":"119","author":"P\u00e1rdutz","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2017.02.053_bb0145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/j.1532-2149.2013.00305.x","article-title":"The l-kynurenine-probenecid combination reduces neuropathic pain in rats","volume":"17","author":"Pineda-Farias","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.jns.2017.02.053_bb0150","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2014"},{"key":"10.1016\/j.jns.2017.02.053_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2016.04.038","article-title":"Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation","volume":"108","author":"Resta","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2017.02.053_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vascn.2015.01.002","article-title":"Telemetry monitoring for non-invasive assessment of changes in core temperature after spinal drug administration in freely moving rats","volume":"72","author":"Safrany-Fark","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jns.2017.02.053_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.03.016","article-title":"Unraveling glutamate-opioid receptor interactions using high-resolution electron microscopy: implications for addiction-related processes","volume":"229","author":"Scavone","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2017.02.053_bb0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/(SICI)1096-9861(19971006)386:4<562::AID-CNE4>3.0.CO;2-0","article-title":"Anatomical distribution of mu, delta, and kappa opioid- and nociceptin\/orphanin FQ-stimulated [35S]guanylyl-5\u2032-O-(gamma-thio)-triphosphate binding in guinea pig brain","volume":"386","author":"Sim","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jns.2017.02.053_bb0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2017.02.053_bb0180","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jns.2017.02.053_bb0185","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.16-13-04162.1996","article-title":"Ultrastructural immunocytochemical localization of \u03bc-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin","volume":"16","author":"Svingos","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2017.02.053_bb0190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jns.2017.02.053_bb0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainresbull.2015.02.001","article-title":"The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level","volume":"112","author":"Tuboly","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jns.2017.02.053_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jns.2017.02.053_bb0205","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","article-title":"The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist","volume":"83","author":"Wong","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.02.053_bb0210","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2174\/1871527314666141205164114","article-title":"Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors","volume":"13","author":"Z\u00e1dor","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jns.2017.02.053_bb2000","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","article-title":"Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington\u2019s disease","volume":"118","author":"Z\u00e1dori","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2017.02.053_bb2005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-4347(95)00341-X","article-title":"Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection","volume":"675","author":"Herv\u00e9","year":"1996","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T20:57:17Z","timestamp":1750021037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1730148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":44,"alternative-id":["S0022510X1730148X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.02.053","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}